Compare
Up to four compounds, side by side.
Useful for choosing between similar peptides or planning a stack.
Add a peptide
| Attribute | Oral GLP-1 (non-peptide) Danuglipron |
|---|---|
| Summary | Pfizer small-molecule oral GLP-1 agonist. |
| Mechanism | Pfizer small-molecule oral GLP-1 agonist. |
| Top outcomes |
|
| Evidence | emerging |
| Half-life | Short (~hours) |
| Administration | oral |
| Legal status | research only |
| Safety | Educational reference only. Long-term human safety varies; consult a peptide-literate clinician. |